Position in ASND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,993,931
+$1,333,093 QoQ
Shares Held
26,222
+6.0% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#109
of 309 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL SARL holds $261,404,130 across 8 Biotechnology names. ASND ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,718 | $104,669,952 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,076,063 | $60,334,852 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
175,542 | $50,024,203 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
58,080 | $17,483,822 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,458 | $15,874,081 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
26,222 | $6,993,931 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
101,238 | $5,521,520 | |
| 8 | CYTK |
Cytokinetics Inc
|
5,890 | $501,769 |
All Filings in ASND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,993,931 | 26,222 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,660,838 | 24,749 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,318,845 | 24,943 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $6,135,674 | 30,862 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,860,588 | 28,161 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,956,038 | 25,382 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,277,372 | 23,806 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||